US 11098283
T cells modified to overexpress c-Myb
granted A61KA61K2035/124A61K2239/38
Quick answer
US patent 11098283 (T cells modified to overexpress c-Myb) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2035/124, A61K2239/38, A61K2239/57, A61K40/11